文献速递分子诊断质量管理与危急值

SARS-CoV-2分子诊断:国际调查结果

Molecular diagnostics of SARS-CoV-2: Findings of an international survey.
PubMed 文献 · Clin Chim Acta · 2022-04-09

国际临床化学与检验医学联合会分子诊断委员会对49个国家273家开展SARS-CoV-2分子检测的实验室进行问卷调查,了解检测方法、流程和质量评估实践。结果显示92.2%实验室使用逆转录聚合酶链反应(RT-PCR),多数不进行变异株鉴定,33.2%未参加外部质量评估。结论认为各国各实验室间SARS-CoV-2分子诊断方法明显未标准化,质量保证执行不足。

要点

  • 92.2%参与调查实验室采用RT-PCR检测SARS-CoV-2。
  • 多数实验室未开展SARS-CoV-2变异株鉴定检测。
  • 33.2%实验室未参加外部质量保证计划。

核心结论

  • 不同国家和实验室的SARS-CoV-2分子诊断方法明显未标准化。
  • 开展SARS-CoV-2检测的诊断实验室质量保证执行不足。

研究设计与样本

  • IFCC分子诊断委员会发起的国际问卷调查,覆盖49个国家273家开展SARS-CoV-2分子遗传检测的实验室。

主要发现

  • 92.2%的参与实验室使用RT-PCR方法检测SARS-CoV-2。
  • 多数参与实验室不进行SARS-CoV-2变异株鉴定检测。
  • 33.2%的实验室报告未参加外部质量保证计划。
  • 调查在样本制备、采集、处理和结果报告方面发现多种不同做法。

临床怎么用

  • 提示实验室应关注SARS-CoV-2分子检测的标准化和外部质量评估参与。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In the current COVID-19 pandemic, early and rapid diagnosis of potentially infected and contagious individuals enables containment of the disease through quarantine and contact tracing. The rapid global expansion of these diagnostic testing services raises questions concerning the current state of the art with regard to standardization of testing and quality assessment practices. The aim of this study was to provide a global overview of the test methods, laboratory procedures and quality assessment practices used for SARS-CoV-2 diagnostics. METHODS: The Molecular Diagnostics Committee of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC C-MD) initiated a survey among international laboratories performing molecular genetic detection of SARS-CoV-2. Questions on quality assurance, variant testing, sequencing and the transmission of findings were included in the survey. RESULTS: A total of 273 laboratories from 49 countries participated in the survey. The majority of the participating laboratories (92.2%) use reverse transcriptase polymerase chain reaction (RT-PCR). The majority of participating laboratories do not conduct testing to identify SARS CoV-2 variants. Participation in external quality assessment programs was reported by the majority of laboratories, however, 33.2% of the laboratories reported not participating in external quality assurance programmes. CONCLUSIONS: Based on the survey, molecular diagnostic methods for SARS-CoV-2 detection are clearly not standardized across different countries and laboratories. The survey found an array of responses in regard to sample preparation, collection, processing and reporting of results. This work suggests quality assurance is insufficiently performed by diagnostic laboratories conducting SARS-CoV-2 testing.

来源:Clin Chim Acta,查看原文。版权归原作者所有。

引用

  1. Vacaflores Salinas A, Ashavaid T, Payne DA, et al. Molecular diagnostics of SARS-CoV-2: Findings of an international survey. Clin Chim Acta. 2022. PMID: 35413298. doi:10.1016/j.cca.2022.04.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。